Search research articles
Contact Us
Filters
Showing results (191-200 of 227) with videos related to
Page
of 23
Sort By:
JAMA Cardiology
|
July 21, 2016
Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome
Paul L Hess, Daniel M Wojdyla, Sana M Al-Khatib, et al.
Circulation
|
June 23, 2025
Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy
Pernille G Thrane, Michael Maeng, Akiko Maehara, et al.
Journal of the American College of Cardiology
|
February 25, 2014
Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial
Kenneth W Mahaffey, Claes Held, Daniel M Wojdyla, et al.
Journal of the American College of Cardiology
|
August 12, 2017
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease
Daniel Lindholm, Johan Lindbäck, Paul W Armstrong, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
April 4, 2024
Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction-Outcomes at two years
Elmir Omerovic, Stefan James, Truls Råmundal, et al.
Circulation
|
December 16, 2022
Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II
Christine Gyldenkerne, Michael Maeng, Lars Kjøller-Hansen, et al.
Lancet (London, England)
|
March 14, 2021
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study
David Erlinge, Akiko Maehara, Ori Ben-Yehuda, et al.
JACC. Cardiovascular Imaging
|
February 25, 2025
Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy
Ketina Arslani, Thomas Engstrøm, Michael Maeng, et al.
Journal of the American College of Cardiology
|
November 12, 2013
Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)
David J Whellan, Pierluigi Tricoci, Edmond Chen, et al.
Circulation
|
December 28, 2018
Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials
Alexander C Fanaroff, Robert Clare, Karen S Pieper, et al.
Page
of 23
Search research articles
Search
Showing results (191-200 of 227) with videos related to
Sort By:
Page
of 23
JAMA Cardiology
|
July 21, 2016
Sudden Cardiac Death After Non-ST-Segment Elevation Acute Coronary Syndrome
Paul L Hess, Daniel M Wojdyla, Sana M Al-Khatib, et al.
Circulation
|
June 23, 2025
Nonculprit Vulnerable Plaques and Prognosis in Myocardial Infarction With Versus Without ST-Segment Elevation: A PROSPECT II Substudy
Pernille G Thrane, Michael Maeng, Akiko Maehara, et al.
Journal of the American College of Cardiology
|
February 25, 2014
Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial
Kenneth W Mahaffey, Claes Held, Daniel M Wojdyla, et al.
Journal of the American College of Cardiology
|
August 12, 2017
Biomarker-Based Risk Model to Predict Cardiovascular Mortality in Patients With Stable Coronary Disease
Daniel Lindholm, Johan Lindbäck, Paul W Armstrong, et al.
Cardiovascular Revascularization Medicine : Including Molecular Interventions
|
April 4, 2024
Bivalirudin versus heparin in ST and non-ST-segment elevation myocardial infarction-Outcomes at two years
Elmir Omerovic, Stefan James, Truls Råmundal, et al.
Circulation
|
December 16, 2022
Coronary Artery Lesion Lipid Content and Plaque Burden in Diabetic and Nondiabetic Patients: PROSPECT II
Christine Gyldenkerne, Michael Maeng, Lars Kjøller-Hansen, et al.
Lancet (London, England)
|
March 14, 2021
Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study
David Erlinge, Akiko Maehara, Ori Ben-Yehuda, et al.
JACC. Cardiovascular Imaging
|
February 25, 2025
Association Between Physiological Significance and Vulnerable Plaque Characteristics in Patients With Myocardial Infarction: A Prospect II Substudy
Ketina Arslani, Thomas Engstrøm, Michael Maeng, et al.
Journal of the American College of Cardiology
|
November 12, 2013
Vorapaxar in acute coronary syndrome patients undergoing coronary artery bypass graft surgery: subgroup analysis from the TRACER trial (Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome)
David J Whellan, Pierluigi Tricoci, Edmond Chen, et al.
Circulation
|
December 28, 2018
Frequency, Regional Variation, and Predictors of Undetermined Cause of Death in Cardiometabolic Clinical Trials: A Pooled Analysis of 9259 Deaths in 9 Trials
Alexander C Fanaroff, Robert Clare, Karen S Pieper, et al.
Page
of 23